4-((TERT-BUTYLDIPHENYLSILYL)OXY)-2,2-DIMETHYLBUTAN-1-OL, 95.0%, 1g

Fmoc-N-(tert-butyloxycarbonylmethyl)glycine, 95%, 1g

Methyl 2-(3-oxocyclobutyl)acetate, 95.0%, 5g

5-Chloro-2-nitrobenzoic acid, min. 98%, for synthesis, 100 g, plastic packaging.

5-Phenylisoxazole, 99.0%, 25g

(L)-4'-Tetrahydropyranylglycine, 95.0%, 1g

4,4',4'',4'''-([2,2'-Bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetrabenzaldehyde, 97%, 50mg

2-[4-(hydroxymethyl)phenyl]acetonitrile, 97%, 500mg

4,4'-(Butane-1,1-diyl)bis(2-(tert-butyl)-5-methylphenol), 95.0%, 500g

3-BROMO-6-CYANO (1H)INDAZOLE, 95%, 5g

3-Amino-2-bromobenzoic acid, 95.0%, 25g

2,4,6-Tris(3-bromophenyl)-1,3,5-triazine>98.0%(HPLC)(N)1g

N,N-Di-n-octyl-3-oxapentanedioic Acid Monoamide>98.0%(GC)(T)5g